Evaluation of the benefit of the bispyridinium compound MB327 for the antidotal treatment of nerve agent-poisoned mice

References

• Alkondon M, Rao KS, Albuquerque EX. (1988). Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel. J Pharmacol Exp Ther 245:543–56
   PubMed Web of Science ®Google Scholar
• Antonijevic B, Stojiljkovic P. (2007). Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 5:71–82
   PubMedGoogle Scholar
• Bajgar J. (2004). Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 38:151–216
   PubMed Web of Science ®Google Scholar
• Becker G, Kawan A, Szinicz L. (1997). Direct reaction of oximes with sarin, soman, or tabun in vitro. Arch Toxicol 71:714–18
   PubMed Web of Science ®Google Scholar
• Eyer P, Szinicz L, Thiermann H, et al. (2007). Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality. Toxicology 233:108–19
   PubMed Web of Science ®Google Scholar
• John H, Mikler J, Worek F, Thiermann H. (2016). Reversed-phase ion-pair chromatography-diode array detection of the bispyridinium compound MB327: plasma analysis of a potential novel antidote for the treatment of organophosphorus poisoning. Drug Test Anal 8:154–63
   PubMed Web of Science ®Google Scholar
• Jokanovic M. (2012). Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data. Curr Topic Med Chem 12:1775–89
   PubMed Web of Science ®Google Scholar
• Jokanovic M, Prostran M. (2009). Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem 16:2177–88
   PubMed Web of Science ®Google Scholar
• Jun D, Kuca K, Stodulka P, et al. (2007). HPLC analysis of HI-6 dichloride and dimethanesulfonate – antidotes against nerve agents and organophosphorus pesticides. Anal Lett 40:2783–7
   Web of Science ®Google Scholar
• Kassa J. (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 40:803–16
   PubMed Web of Science ®Google Scholar
• Kassa J, Misik J, Zdarova Karasova J. (2015). Neuroprotective efficacy of newly developed oximes in comparison with currently available oximes in tabun-poisoned rats. J Appl Biomed 13:39–46
   Web of Science ®Google Scholar
• Kassa J, Musilek K, Zdarova Karasova J, et al. (2012). Two possibilities how to increase the efficacy of antidotal treatment of nerve agent poisonings. Mini Rev Med Chem 12:24–34
   PubMed Web of Science ®Google Scholar
• Kloog Y, Galron R, Sokolovsky M. (1986). Bisquaternary pyridinium oximes as presynaptic agonists and postsynaptic antagonists of muscarinic receptors. J Neurochem 46:767–72
   PubMed Web of Science ®Google Scholar
• Königer C, Worek F, Thiermann H, Wille T. (2013). Effect of MB327 and oximes on rat intestinal smooth muscle function. Chem Biol Interact 204:1–5
   PubMed Web of Science ®Google Scholar
• Leibson T, Lifshitz M. (2008). Organophosphate and carbamate poisoning: review of the current literature and summary of clinical and laboratory experience in southern Israel. Isr Med Assoc J 10:767–70
   PubMed Web of Science ®Google Scholar
• Lotti M. (2000). Organophosphorus compounds. In Spencer PS, Schaumburg HH, eds. Experimental and clinical neurotoxicology. New York: Oxford University Press, 898–925
   Google Scholar
• Marrs TC, Rice P, Vale JA. (2006). The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 25:297–323
   PubMedGoogle Scholar
• McDonough JH, Shih TM. (2007). Atropine and other anticholinergic drugs. In: Marrs TC, Maynard RI, Sidell FR, eds. Chemical warfare agents: toxicology and treatment. 2nd ed. Chichester, UK: John Wiley & Sons Ltd, 287–303
   Google Scholar
• Niessen KV, Seeger T, Tattersall JEH, et al. (2013). Affinities of bispyridinium non-oxime compounds to [3H]epibatidine binding sites of Torpedo californica nicotinic acetylcholine receptors depend on linker length. Chem Biol Interact 206:545–54
   PubMed Web of Science ®Google Scholar
• Niessen KV, Tattersall JEH, Timperley CM, et al. (2011). Interaction of bispyridinium compounds with the orthosteric binding site of human α7 and Torpedo californica nicotinic acetylcholine receptors (nAChRs). Toxicol Lett 206:100–4
   PubMed Web of Science ®Google Scholar
• Niessen KV, Tattersall JEH, Timperley CM, et al. (2012). Competition radioligand binding assays for the investigation of bispyridinium compound affinities to the human muscarinic acetylcholine receptor subtype 5 (hM5). Drug Test Anal 4:292–7
   PubMed Web of Science ®Google Scholar
• Nurulain SM. (2011). Efficacious oxime for organophosphorus poisoning: a minireview. Trop J Pharm Res 10:341–9
   Web of Science ®Google Scholar
• Price ME, Docx CJ, Rice H, et al. (2016). Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig. Toxicol Lett 244:154–60
   PubMed Web of Science ®Google Scholar
• Reddy VK, Deshpande SS, Cintra WM, et al. (1991). Effectiveness of oximes 2-PAM and HI-6 in recovery of muscle function depressed by organophosphate agents in the rat hemidiaphragm: an in vitro study. Fundam Appl Toxicol 17:746–60
   PubMedGoogle Scholar
• Rice H, Dalton CH, Price ME, et al. (2015). Toxicity and medical countermeasure studies on the organophosphorus nerve agents VM and VX. Proc R Soc A 471:20140891
   Google Scholar
• Ring A, Strom BO, Turner SR, et al. (2015). Bispyridinium compounds inhibit both muscle and neuronal nicotinic acetylcholine receptors in human cell lines. PLoS One 10:e0135811. doi:10.1371/jounal.pone.0135811
   PubMed Web of Science ®Google Scholar
• Seeger T, Eichhorn M, Lindner M, et al. (2012). Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro. Toxicology 294:80–4
   PubMed Web of Science ®Google Scholar
• Sevelova L, Kuca K, Krejcova Kunesova G. (2005). Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes. Toxicology 207:1–6
   PubMed Web of Science ®Google Scholar
• Tallarida R, Murray R. (1987). Manual of pharmacological calculation with computer programs. New York: Springer-Verlag
   Google Scholar
• Tattersall JEH. (1993). Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 108:1006–15
   PubMed Web of Science ®Google Scholar
• Timperley CM. (2000). Highly-toxic fluorine compounds. In: Banks RE, ed. Fluorine chemistry at the millennium – fascinated by fluorine. Oxford, UK: Elsevier, Chapter 29, 499–538
   Google Scholar
• Timperley CM, Banks RE, Young IM, Haszeldine RN. (2011). Synthesis of some fluorine-containing pyridinealdoximes of potential use for the treatment of organophosphorus nerve-agent poisoning. J Fluorine Chem 132:541–7
   Web of Science ®Google Scholar
• Timperley CM, Bird M, Green C, et al. (2012). 1,1'-(Propane-1,3-diyl)bis(4-tert-butylpyridinium) di(methanesulfonate) protects guinea pigs from soman poisoning when used as part of a combined therapy. Med Chem Commun 3:352–6
   Web of Science ®Google Scholar
• Timperley CM, Bird M, Heard SC, et al. (2005). Fluorinated pyridine derivatives Part 1. The synthesis of some mono- and bis-quaternary pyridine salts of potential use in the treatment of nerve agent poisoning. J Fluorine Chem 126:1160–5
   Web of Science ®Google Scholar
• Timperley CM, Tattersall JEH. (2015). Toxicology and medical treatment of organophosphorus compounds. In: Timperley CM, ed. Best synthetic methods – organophosphorus (V) chemistry. Oxford, UK: Elsevier, Chapter 1.10, 33–89
   Google Scholar
• Turner SR, Chad JE, Price M, et al. (2011). Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist. Toxicol Lett 206:105–11
   PubMed Web of Science ®Google Scholar
• Van Helden HPM, Busker RW, Melchers BPC, Bruijnzeel PLB. (1996). Pharmacological effects of oximes: how relevant are they? Arch Toxicol 70:779–86
   PubMed Web of Science ®Google Scholar
• Van Helden HPM, Van der Wiel HJ, Zijlstra JJ, et al. (1994). Comparison of the therapeutic effects and pharmacokinetics of HI-6, Hlö-7, HGG-12. HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats. Arch Toxicol 68:224–30
   PubMed Web of Science ®Google Scholar
• Worek F, Thiermann H, Szinicz L, Eyer P. (2004). Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 68:2237–48
   PubMed Web of Science ®Google Scholar